menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Elevating the Treatment of Acne Through Patient & Physician Dialogues

Program Information
Recommended

Program Information

Elevating the Treatment of Acne Through Patient & Physician Dialogues
RestartResume

As dermatologists, we have a direct line of communication with our patients and can help them find a solution for their facial and truncal acne.

  • Sponsored by

  • Overview

    For the millions of Americans living with acne, the conversation has been primarily focused on facial acne, overlooking other areas of the body. That’s why it’s so important to ask the right questions about a patient’s acne—even the acne we can’t see—in addition to offering solutions for achieving clearer skin on the face and trunk, as Dr. Mona Gohara explains.

    IMPORTANT SAFETY INFORMATION (ISI)

    INDICATION: AKLIEF® (trifarotene) Cream, 0.005% is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. ADVERSE EVENTS: The most common adverse reactions (incidence ≥ 1%) in patients treated with AKLIEF Cream were application site irritation, application site pruritus (itching), and sunburn. WARNINGS/PRECAUTIONS: Patients using AKLIEF Cream may experience erythema, scaling, dryness, and stinging/burning. Use a moisturizer from the initiation of treatment, and, if appropriate, depending upon the severity of these adverse reactions, reduce the frequency of application of AKLIEF Cream, suspend or discontinue use. Avoid application of AKLIEF Cream to cuts, abrasions or eczematous or sunburned skin. Use of “waxing” as a depilatory method should be avoided on skin treated with AKLIEF Cream. Minimize exposure to sunlight and sunlamps. Use sunscreen and protective clothing over treated areas when exposure cannot be avoided.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

    © 2021 Galderma Laboratories, L.P. All Rights Reserved. All trademarks are the property of their respective owners.

Programs 7/29/21